137 related articles for article (PubMed ID: 15016076)
21. Impaired conditioned taste aversion learning in APP transgenic mice.
Janus C; Welzl H; Hanna A; Lovasic L; Lane N; St George-Hyslop P; Westaway D
Neurobiol Aging; 2004 Oct; 25(9):1213-9. PubMed ID: 15312967
[TBL] [Abstract][Full Text] [Related]
22. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene.
Groner Y; Elroy-Stein O; Avraham KB; Yarom R; Schickler M; Knobler H; Rotman G
J Physiol (Paris); 1990; 84(1):53-77. PubMed ID: 1972759
[TBL] [Abstract][Full Text] [Related]
23. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice.
Hyde LA; Kazdoba TM; Grilli M; Lozza G; Brusa R; Zhang Q; Wong GT; McCool MF; Zhang L; Parker EM; Higgins GA
Behav Brain Res; 2005 May; 160(2):344-55. PubMed ID: 15863231
[TBL] [Abstract][Full Text] [Related]
24. The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome.
Seo H; Isacson O
J Neurochem; 2010 Sep; 114(6):1819-26. PubMed ID: 20698932
[TBL] [Abstract][Full Text] [Related]
25. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected].
Lamb BT; Sisodia SS; Lawler AM; Slunt HH; Kitt CA; Kearns WG; Pearson PL; Price DL; Gearhart JD
Nat Genet; 1993 Sep; 5(1):22-30. PubMed ID: 8220418
[TBL] [Abstract][Full Text] [Related]
26. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling.
Shimazawa M; Inokuchi Y; Okuno T; Nakajima Y; Sakaguchi G; Kato A; Oku H; Sugiyama T; Kudo T; Ikeda T; Takeda M; Hara H
J Neurochem; 2008 Oct; 107(1):279-90. PubMed ID: 18691390
[TBL] [Abstract][Full Text] [Related]
27. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.
Jhoo JH; Kim HC; Nabeshima T; Yamada K; Shin EJ; Jhoo WK; Kim W; Kang KS; Jo SA; Woo JI
Behav Brain Res; 2004 Dec; 155(2):185-96. PubMed ID: 15364477
[TBL] [Abstract][Full Text] [Related]
28. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice.
Seo H; Isacson O
Exp Neurol; 2005 Jun; 193(2):469-80. PubMed ID: 15869949
[TBL] [Abstract][Full Text] [Related]
29. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes.
Hermann D; Both M; Ebert U; Gross G; Schoemaker H; Draguhn A; Wicke K; Nimmrich V
Neuroscience; 2009 Sep; 162(4):1081-90. PubMed ID: 19477243
[TBL] [Abstract][Full Text] [Related]
30. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.
Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M
Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461
[TBL] [Abstract][Full Text] [Related]
31. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
[TBL] [Abstract][Full Text] [Related]
32. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside.
Zhang L; Xing Y; Ye CF; Ai HX; Wei HF; Li L
Behav Brain Res; 2006 Oct; 173(2):246-54. PubMed ID: 16901557
[TBL] [Abstract][Full Text] [Related]
33. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the human beta-amyloid precursor protein downregulates cortistatin mRNA in PDAPP mice.
Winsky-Sommerer R; Spier AD; Fabre V; de Lecea L; Criado JR
Brain Res; 2004 Oct; 1023(1):157-62. PubMed ID: 15364032
[TBL] [Abstract][Full Text] [Related]
35. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
36. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease.
Lovasic L; Bauschke H; Janus C
Genes Brain Behav; 2005 Apr; 4(3):197-208. PubMed ID: 15810906
[TBL] [Abstract][Full Text] [Related]
37. Inverse correlation between amyloid precursor protein and synaptic plasticity in transgenic mice.
Matsuyama S; Teraoka R; Mori H; Tomiyama T
Neuroreport; 2007 Jul; 18(10):1083-7. PubMed ID: 17558301
[TBL] [Abstract][Full Text] [Related]
38. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.
Szapacs ME; Numis AL; Andrews AM
Neurobiol Dis; 2004 Aug; 16(3):572-80. PubMed ID: 15262269
[TBL] [Abstract][Full Text] [Related]
39. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
Breyhan H; Wirths O; Duan K; Marcello A; Rettig J; Bayer TA
Acta Neuropathol; 2009 Jun; 117(6):677-85. PubMed ID: 19387667
[TBL] [Abstract][Full Text] [Related]
40. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
